SUMMARY: President-elect Donald Trump nominated celebrity doctor Mehmet Oz to head the Centers for Medicare & Medicaid Services (CMS). Oz, known for his investments in healthcare, tech, and food companies, holds significant stakes in UnitedHealth Group, CVS Health, Amazon, and other companies involved in health insurance and pharmaceuticals, raising potential conflicts of interest. His financial ties include hospital stocks and pharmaceutical investments. Oz has expressed support for Medicare Advantage and criticized the food and healthcare industries. Critics question whether Oz can separate his financial interests from his role, particularly with companies doing business with the federal government.

Read the full article

The post TV’s Dr. Oz Invested in Businesses Regulated by Agency Trump Wants Him To Lead appeared first on kffhealthnews.org

SUMMARY: Florida’s plan to import lower-cost prescription drugs from Canada, approved by the FDA nearly a year ago, has yet to launch. Governor Ron DeSantis praised the program, anticipated to save state agencies up to $180 million, but officials lack a start date. Despite bipartisan support for drug importation, complications persist, including operational challenges and safety concerns from the pharmaceutical industry. DeSantis has filed lawsuits against the FDA for delays and Florida has already spent $50 million on the initiative with no drugs imported. Other states, like Colorado, face similar hurdles in establishing importation programs.

Read the full article

The post Florida Gov. DeSantis’ Canadian Drug Import Plan Goes Nowhere After FDA Approval appeared first on kffhealthnews.org

SUMMARY: Donald Trump’s return to the White House may inspire Republicans to weaken or repeal the Affordable Care Act (ACA), but significant procedural and political challenges remain. Trump has opposed the ACA and is interested in reforming it, while GOP lawmakers aim to revamp the 2010 health law, citing costs and government overreach. Potential changes could affect Medicaid expansion, raise the uninsured rate, and increase premiums. Trump could use reconciliation to change the ACA without Democratic votes, or pursue executive actions to modify it. Critics worry that policies could lead to higher costs and reduced protections for individuals with preexisting conditions.

Read the full article

The post Washington Power Has Shifted. Here’s How the ACA May Shift, Too. appeared first on kffhealthnews.org